Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.15 -1.97% 7.45 7.20 7.70 7.60 7.45 7.60 154,860 12:32:54
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.2 -2.1 - 20

Evgen Pharma Share Discussion Threads

Showing 8126 to 8149 of 8400 messages
Chat Pages: 336  335  334  333  332  331  330  329  328  327  326  325  Older
DateSubjectAuthorDiscuss
09/4/2021
20:48
Lol...don't take wet mate, there's been 30 recorded cases and 7 recorded deaths in the UK of blood clots that have looked unusual because of low platelet counts, yet 18m plus people have had the AZ jab, and they reckon those with Covid stand a 1 in 6 chance of getting a blood clot, and hundreds if not thousands are dying in Europe..4 thousand plus died in Brazil yesterday, yet the UK numbers for deaths, infections and hospitalisation are at an all time low, yet the majority of Europe are in or are planning a third lockdown...almost 40% UK citizens vaccinated, and only 12% of the whole of Europe...Boris deserves a medal....the Brits will be going on holiday in July and August because of low numbers of cases, but they certainly won't going to mainland Europe unless things drastically change...which appears unlikely. Gl ;') Ps can't wait for my second AZ jab....;-)
moneymunch
09/4/2021
20:44
anyone here into Crypto ? Shard coin about to be listed on ETH and BSC in the next 2 weeks.. will be a quick few hundred % profit hTTps://shardcoinofficial.medium.com/shard-chain-swap-and-shardnomics-a4b77985490c
dlg3
09/4/2021
20:40
The United Kingdom decided on Wednesday to limit the use of the AstraZeneca vaccine to people under the age of 30. Makes it harder to explain why a 30 year old healthy person dies of blood clots, so that is the reason for the age limit put at 30, a 34 year old nurse in Portugal died after having AZ jab,perfectly healthy beforehand.... that is the trouble when there is a race on, things get overlooked and the UK gov. may come to regret rushing ahead..
dlg3
09/4/2021
20:28
money come back in a month,s time, the third wave will be hitting the UK, figures still higher than July and August 2020..the correct figures for blood clots not fully documented, I know of six people that have died of blood clots after having AZ jab, the uk gov. will be pooing their pants after going ahead with no responsibility falling back on to AZ...and the Tax payer having to foot the bill....
dlg3
09/4/2021
19:30
Meanwhile here, the pubs are opening up on Monday. Cheers :-)
moneymunch
09/4/2021
19:26
Lol, I've had my AZ jab and proud to have it, Europe and the majority of the rest of the World appears to be in a right mess, the pandemic is surging out of control in many of the countries that have been anti-AZ...Gl :-)
moneymunch
09/4/2021
18:49
Quick someone give Johnson his second shot of the Astra jab, or will he not be taking it now ???
dlg3
09/4/2021
18:48
yes Prince Philipp had the astra jab and ended up in hospital 3 weeks later with his ticker, coincidence ???? there is a reason that astra wanted not to be held responsible if something went wrong !!!! Now the Government (or should I say the Tax payers) are picking up Astra claims tab..going to cost a fortune, no wonder the UK government are playing down the blood clot problem..... Press release Government to add COVID-19 to Vaccine Damage Payments Scheme
dlg3
09/4/2021
17:51
why would you want a blood clot, Azn have a jab if that's any good ..
dutch123
09/4/2021
15:32
Has EVG got anything for blood clots?
alancapone
09/4/2021
15:19
Multiple newsflow expected from Huw across the pipeline, including Prof Chalmers preliminary efficacy assessment for Covid/ARDS, where positive data will be a complete game changer for all invested, and news on the IND could also be close which could be very well received. Momentum and excitement building in anticipation. Gla ;-) SIGNIFICANT LANDMARK An ambition (and a potential significant landmark/catalyst for the business) will be the filing of an investigational new drug application (IND) in the US for SFX-01, though medical indication for the drug hasn’t been decided.
moneymunch
08/4/2021
22:40
nearly £500,000 trade, looks like someone knows something..
dlg3
08/4/2021
22:38
Price has been held back to fill those chunky trades, this will rocket once they let it go....
dlg3
08/4/2021
19:53
Wow, a chunky trade indeed...news coming soon I reckon. :-)
moneymunch
08/4/2021
19:14
Even chunkier 5,497,762 trade just shown. Fingers crossed this is the end of the anchor.
on target
08/4/2021
14:21
Some nice chunky buys hoovering UP the cheap shares, as usual....back to double figures soon enough imho in anticipation of multiple material newsflow expected from Huw this Q2....Gla ;-)
moneymunch
07/4/2021
21:58
Maybe an opportune time to report any progress on any oncology target. Gla :-) AACR ANNUAL MEETING 2021Virtual MeetingWeek 1: April 10-15; Week 2: May 17-21 The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. htTps://www.aacr.org/meeting/aacr-annual-meeting-2021/
moneymunch
07/4/2021
21:18
James Chalmers United Kingdom James Chalmers is Professor of Respiratory Medicine at the University of Dundee and a consultant physician. Graduating from the University of Glasgow’s School of Medicine, he has since gone on to obtain a doctorate from the University of Edinburgh, and is now a member of Edinburgh’s Royal College of Physicians. He has published more than 200 peer reviewed papers, chairs the European Bronchiectasis Registry, and serves regularly as a reviewer for each of the major respiratory medicine journals (American Journal of Respiratory and Critical Care Medicine, Thorax, European Respiratory Journal, Chest, Respiratory Medicine). His research operates at both translating basic discoveries into therapies, and translating therapies into clinical practice, and has deliberately focussed on areas of perceived need in respiratory medicine, with high morbidity and mortality but limited investment in research. ........ Background The DRAGON project is coordinated by the University of Maastricht with Radiomics as the Project Lead, and partners comprised of high-tech small and medium-sized enterprises (SMEs), academic research institutes, biotechnology and pharmacological partners, and ELF and ERS. Funded by the Innovative Medicines Initiative (IMI), it will use AI and machine learning to deliver a patient-centred decision support system that will enable stakeholders to participate in the development of rapid precise diagnosis and prognosis. “The application of digital imaging together with clinical data to inform clinical decisions through artificial intelligence is very exciting.  The DRAGON project offers to do this as part of our response to the pandemic.” 
moneymunch
07/4/2021
21:06
All welcome to the other Evgen thread, including you nobby, apart from those intent on destruction and mindless distraction...On and UP!!! :-) hTtps://uk.advfn.com/cmn/fbb/thread.php3?id=47886656
moneymunch
07/4/2021
20:50
Prof Chalmers, Lead investigator for SFX-01 Covid/ARDS patient trials, is on the organisation committee for the following event, and so every chance that he could be reporting good news on SFX-01's efficacy for Covid/Ards 29th April 2021.Gla ;-) COVID-19: State of the art – DRAGON IMI project 29 April, 2021 Online A full-day virtual event dedicated to COVID-19, where top level faculty will share the latest advances, data and best practices relating to SARS-CoV-2 and COVID-19. “This event brings together world-leaders tackling COVD-19 and how different digital approaches to big data will help us to defeat the pandemic” – Professor Christopher Brightling, event co-chair. htTps://www.ersnet.org/events/covid-19-state-of-the-art-dragon-imi-project/?preview_id=129976
moneymunch
07/4/2021
19:55
Covid-19 pandemic seems to be surging out of control around the rest of the World, and so the upside here could be "breathtaking" if Prof Chalmers confirms SFX-01's efficacy....there are very few ( if any ) clear cut effective treatments that come anywhere near to the therapeutic benefits documented by John Hopkins University suggesting Sulforaphane as a promising treatment for Covid-19 and many variants as well as ARDS etc, and so can you imagine if the potent synthetic form of Sulforaphane, SFX-01, has a similar confirmed effect???!!!!...it seems like the risk reward is firmly tipped towards our favour.:-)
moneymunch
07/4/2021
18:39
Anytime soon On target, and the accumulation of cheap shares continues in anticipation. Gl :-)
moneymunch
07/4/2021
18:02
More meaty trades reported after the bell. Can't be much longer until this shareprice breaks free of its reins?
on target
07/4/2021
15:45
Professor_Peaky14 Feb '21 - 21:23 - 19 of 625 0 3 0 Dear Shoddy, i hear you are shorting this? HodHasharon14 Feb '21 - 21:27 - 20 of 625 0 0 1 Only a fool would short EVG. You shorting it Peaky? Professor_Kemche14 Feb '21 - 21:31 - 21 of 625 0 0 0 Id happily short your mum tho
andymunchkin
Chat Pages: 336  335  334  333  332  331  330  329  328  327  326  325  Older
ADVFN Advertorial
Your Recent History
LSE
EVG
Evgen Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210515 09:16:53